← Back
Data updated: Mar 10, 2026
XTM CONSULTING
Pharmaceuticals
XTM CONSULTING is a pharmaceutical company with 1 FDA-approved products.
2025
Since
1
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LOPRESSOR 2025-11-12
Labeling
LOPRESSOR 2025-08-28
Type 5 - New Formulation or New Manufacturer
LOPRESSOR 2025-04-10
Type 3 - New Dosage Form
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2025-08-28
- Latest
- 2025-08-28
- Applications
- 1